Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Zynerba Pharmaceuticals I...

    NASDAQ: ZYNE · Real-Time Price · USD
    1.30
    0.03 (2.36%)
    At close: Oct 10, 2023, 10:00 PM

    Zynerba Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a
    Cost of Revenue
    		 n/a n/a
    Gross Profit
    		 n/a n/a
    Operating Income
    		 -35.25M -36.77M
    Interest Income
    		 846.86K 21.05K
    Pretax Income
    		 -35.04M -37.31M
    Net Income
    		 -34.82M -37.6M
    Selling & General & Admin
    		 14.15M 15.35M
    Research & Development
    		 21.1M 21.42M
    Other Expenses
    		 n/a n/a
    Operating Expenses
    		 35.25M 36.77M
    Interest Expense
    		 -215.73K n/a
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 35.25M 36.77M
    Income Tax Expense
    		 -215.73K 291.49K
    Shares Outstanding (Basic)
    		 42.66M 39.26M
    Shares Outstanding (Diluted)
    		 42.66M 39.26M
    EPS (Basic)
    		 -0.82 -0.96
    EPS (Diluted)
    		 -0.82 -0.96
    EBITDA
    		 -34.62M -36.21M
    EBIT
    		 -35.25M -36.77M
    Depreciation & Amortization
    		 631.13K 559.68K

    Add to Watchlist